These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9843424)

  • 1. Molecular basis for p38 protein kinase inhibitor specificity.
    Lisnock J; Tebben A; Frantz B; O'Neill EA; Croft G; O'Keefe SJ; Li B; Hacker C; de Laszlo S; Smith A; Libby B; Liverton N; Hermes J; LoGrasso P
    Biochemistry; 1998 Nov; 37(47):16573-81. PubMed ID: 9843424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
    Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
    Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
    Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket.
    Gum RJ; McLaughlin MM; Kumar S; Wang Z; Bower MJ; Lee JC; Adams JL; Livi GP; Goldsmith EJ; Young PR
    J Biol Chem; 1998 Jun; 273(25):15605-10. PubMed ID: 9624152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of inhibitor selectivity in MAP kinases.
    Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
    Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket.
    Tong L; Pav S; White DM; Rogers S; Crane KM; Cywin CL; Brown ML; Pargellis CA
    Nat Struct Biol; 1997 Apr; 4(4):311-6. PubMed ID: 9095200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic mechanism for p38 MAP kinase.
    LoGrasso PV; Frantz B; Rolando AM; O'Keefe SJ; Hermes JD; O'Neill EA
    Biochemistry; 1997 Aug; 36(34):10422-7. PubMed ID: 9265622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
    Eyers PA; Craxton M; Morrice N; Cohen P; Goedert M
    Chem Biol; 1998 Jun; 5(6):321-8. PubMed ID: 9653550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
    Young PR; McLaughlin MM; Kumar S; Kassis S; Doyle ML; McNulty D; Gallagher TF; Fisher S; McDonnell PC; Carr SA; Huddleston MJ; Seibel G; Porter TG; Livi GP; Adams JL; Lee JC
    J Biol Chem; 1997 May; 272(18):12116-21. PubMed ID: 9115281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
    Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
    Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for selective inhibition of Src family kinases by PP1.
    Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
    Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.
    Goedert M; Cuenda A; Craxton M; Jakes R; Cohen P
    EMBO J; 1997 Jun; 16(12):3563-71. PubMed ID: 9218798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
    Fricker M; Lograsso P; Ellis S; Wilkie N; Hunt P; Pollack SJ
    Arch Biochem Biophys; 2005 Jun; 438(2):195-205. PubMed ID: 15907786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
    Rosenberger SF; Gupta A; Bowden GT
    Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
    McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
    J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
    Kumar S; McDonnell PC; Gum RJ; Hand AT; Lee JC; Young PR
    Biochem Biophys Res Commun; 1997 Jun; 235(3):533-8. PubMed ID: 9207191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
    Alexander LD; Cui XL; Falck JR; Douglas JG
    Kidney Int; 2001 Jun; 59(6):2039-53. PubMed ID: 11380805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase.
    Wang XS; Diener K; Manthey CL; Wang S; Rosenzweig B; Bray J; Delaney J; Cole CN; Chan-Hui PY; Mantlo N; Lichenstein HS; Zukowski M; Yao Z
    J Biol Chem; 1997 Sep; 272(38):23668-74. PubMed ID: 9295308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.